Literature DB >> 16204648

Decreased clearance of Pseudomonas aeruginosa from airways of mice deficient in lysozyme M.

Alexander M Cole1, Dharma R Thapa, Victoria Gabayan, Hsiang-I Liao, Lide Liu, Tomas Ganz.   

Abstract

Lysozyme is a ubiquitous and abundant, cationic, antimicrobial polypeptide of leukocytes and epithelia, but its biological function in host defense is largely unexplored. To ascertain the role of lysozyme during bacterial infection of murine airways, we exposed the airways of lysozyme M-deficient (lys M-/-) mice to the pulmonary pathogen Pseudomonas aeruginosa and examined the host's response to infection. Despite partial compensation as a result of the appearance of lysozyme P in the infected airways of lys M-/- mice, these lys M-/- mice showed decreased clearance of P. aeruginosa compared with their lys M+/- or lys M+/+ littermates. Lysozyme contributes to optimal clearance of P. aeruginosa from the murine airways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204648     DOI: 10.1189/jlb.0205073

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  17 in total

Review 1.  Lysozymes in the animal kingdom.

Authors:  Lien Callewaert; Chris W Michiels
Journal:  J Biosci       Date:  2010-03       Impact factor: 1.826

2.  A Moraxella catarrhalis two-component signal transduction system necessary for growth in liquid media affects production of two lysozyme inhibitors.

Authors:  Stephanie N Joslin; Christine Pybus; Maria Labandeira-Rey; Amanda S Evans; Ahmed S Attia; Chad A Brautigam; Eric J Hansen
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

3.  Arsenic alters transcriptional responses to Pseudomonas aeruginosa infection and decreases antimicrobial defense of human airway epithelial cells.

Authors:  Britton C Goodale; Erica J Rayack; Bruce A Stanton
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-15       Impact factor: 4.219

4.  Mutations of the Listeria monocytogenes peptidoglycan N-deacetylase and O-acetylase result in enhanced lysozyme sensitivity, bacteriolysis, and hyperinduction of innate immune pathways.

Authors:  Chris S Rae; Aimee Geissler; Paul C Adamson; Daniel A Portnoy
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

5.  Exposure of Pseudomonas aeruginosa to bactericidal hypochlorous acid during neutrophil phagocytosis is compromised in cystic fibrosis.

Authors:  Nina Dickerhof; Vivienne Isles; Philip Pattemore; Mark B Hampton; Anthony J Kettle
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

6.  Enhanced antimicrobial activity of engineered human lysozyme.

Authors:  Thomas C Scanlon; Charlotte C Teneback; Avinash Gill; Jenna L Bement; Joshua A Weiner; John W Lamppa; Laurie W Leclair; Karl E Griswold
Journal:  ACS Chem Biol       Date:  2010-09-17       Impact factor: 5.100

7.  Increased susceptibility to pulmonary Pseudomonas infection in Splunc1 knockout mice.

Authors:  Yanyan Liu; Marissa E Di; Hong Wei Chu; Xinyu Liu; Ling Wang; Sally Wenzel; Y Peter Di
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

8.  Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice.

Authors:  Cecilia G Clement; Scott E Evans; Christopher M Evans; David Hawke; Ryuji Kobayashi; Paul R Reynolds; Seyed J Moghaddam; Brenton L Scott; Ernestina Melicoff; Roberto Adachi; Burton F Dickey; Michael J Tuvim
Journal:  Am J Respir Crit Care Med       Date:  2008-04-03       Impact factor: 21.405

Review 9.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

10.  Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia.

Authors:  Andrew Y Koh; Gregory P Priebe; Christopher Ray; Nico Van Rooijen; Gerald B Pier
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.